Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Bowman Consulting
BWMN
$732M
| $1.01M | ﹤0.01% |
28,506
+870
| +3% | +$26K |
|
|
LGTY
2827
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $1.01M | ﹤0.01% |
89,201
| – | – |
|
2828
Hippo Holdings
HIPO
$868M
| $1.01M | ﹤0.01% |
110,505
+1,400
| +1% | +$11.6K |
|
|
GOEV
2829
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $1.01M | ﹤0.01% |
8,510
+3,682
| +76% | +$499K |
|
|
IGMS
2830
DELISTED
IGM Biosciences
IGMS
| $1M | ﹤0.01% |
120,817
+21,052
| +21% | +$122K |
|
2831
SGHC Ltd
SGHC
$6.51B
| $1M | ﹤0.01% |
316,048
| – | – |
|
|
AKYA
2832
DELISTED
Akoya BioSciences
AKYA
| $1,000K | ﹤0.01% |
204,849
+51,410
| +34% | +$214K |
|
|
TSP
2833
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $999K | ﹤0.01% |
1,138,011
+36,216
| +3% | +$37K |
|
2834
Nomura Holdings
NMR
$29B
| $998K | ﹤0.01% |
221,306
+93,200
| +73% | +$383K |
|
|
LOVE
2835
LoveSac
LOVE
$253M
| $997K | ﹤0.01% |
39,026
| – | – |
|
2836
AirSculpt Technologies
AIRS
$234M
| $997K | ﹤0.01% |
133,084
-3,624
| -3% | -$23K |
|
2837
Ocular Therapeutix
OCUL
$2.25B
| $987K | ﹤0.01% |
221,202
+6,787
| +3% | +$20.1K |
|
|
KALV
2838
DELISTED
KalVista Pharmaceuticals
KALV
| $986K | ﹤0.01% |
80,451
+15,297
| +23% | +$139K |
|
2839
CVRx
CVRX
$72.7M
| $982K | ﹤0.01% |
31,233
| – | – |
|
2840
Limoneira
LMNR
$251M
| $981K | ﹤0.01% |
47,543
+295
| +0.6% | +$4.77K |
|
2841
Oric Pharmaceuticals
ORIC
$1.43B
| $981K | ﹤0.01% |
106,601
+719
| +0.7% | +$5.2K |
|
|
SMMF
2842
DELISTED
Summit Financial Group, Inc.
SMMF
| $978K | ﹤0.01% |
31,878
+73
| +0.2% | +$1.76K |
|
|
CSTR
2843
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $978K | ﹤0.01% |
52,203
| – | – |
|
2844
Nutrien
NTR
$32.1B
| $976K | ﹤0.01% |
+17,320
| New | +$979K |
|
2845
Boston Omaha
BOC
$436M
| $973K | ﹤0.01% |
61,885
-112
| -0.2% | -$1.7K |
|
2846
iRadimed
IRMD
$1.12B
| $972K | ﹤0.01% |
20,483
| – | – |
|
2847
Lloyds Banking Group
LYG
$89.8B
| $954K | ﹤0.01% |
399,179
+138,829
| +53% | +$297K |
|
2848
Bioventus
BVS
$1.17B
| $951K | ﹤0.01% |
180,546
+3,198
| +2% | +$12.7K |
|
2849
Avita Medical
RCEL
$251M
| $947K | ﹤0.01% |
69,032
| – | – |
|
2850
Esquire Financial Holdings
ESQ
$1.15B
| $947K | ﹤0.01% |
18,954
-579
| -3% | -$27.2K |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.